Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 17Recruiting 4Terminated 3Unknown 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 4FED 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Breast 1

Conditions

Prostatic Neoplasms 2Hypogonadism 2Neoplasms 1Fatigue 1Eunuchism 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Magnetic Resonance Spectroscopy 332Specimen Handling 331Radiotherapy 315Cyclophosphamide 298pembrolizumab 286Cisplatin 270Carboplatin 247Drug Therapy 238Blood Specimen Collection 234Biopsy 203Bevacizumab 185Gemcitabine 181venetoclax 177Radiosurgery 170Oxaliplatin 164Capecitabine 163fludarabine 161Paclitaxel 158Nivolumab 157Standard of Care 135Surveys and Questionnaires 132Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 123Rituximab 113Docetaxel 112tislelizumab 111Cytarabine 106toripalimab 101Radiation 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Testosterone × Clear all
NCT06075953 2026-05-22

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
400 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Roswell Park Cancer Institute

Phase 4 Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting
230 enrolled

Eunuchism, Fatigue, Hypogonadism, Neoplasms

NCT04833426 2025-05-02

ENFORCE

Canisius-Wilhelmina Hospital

Phase 3 Recruiting
140 enrolled
Genitourinary

Hypogonadism, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡